However, these results must be contextualised carefully: Phase 2 trials are not powered to detect cardiovascular outcomes such as myocardial infarction, stroke, or cardiovascular mortality No dedicated cardiovascular outcome trial (CVOT) data exist for retatrutide such trials are required before definitive conclusions about cardiovascular benefit or risk can be drawn
The UK Chief Medical Officers' Physical Activity Guidelines recommend that adults should aim for at least 150 minutes of moderate-intensity aerobic activity weekly, alongside muscle-strengthening activities on two or more days
Xu, Y., Guo, N., Dou, D., Ran, X
Semabest 4mg Injection is used for cardiovascular risk reduction and weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have at least one related health condition